1.Heron, D E, Andrade, R S, Beriwal, Set al. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response. Am J Clin Oncol 2008; 31 (4): 352–362.
2.Ciernik, I F, Dizendorf, E, Baumert, B Get al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57 (3): 853–863.
3.Deantonio, L, Beldi, D, Gambaro, Get al. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiother Oncol 2008; 3: 29.
4.Heron, D E, Andrade, R S, Flickinger, Jet al. Hybrid PET-CT simulation for radiation treatment planning in head and neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys 2004; 60: 1419–1424.
5.Vernon, M R, Maheshwari, M, Schultz, C Jet al. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 2008; 70 (3): 678–684.
6.Rothschild, S, Studer, G, Seifert, Bet al. PET/CT staging followed by intensity-modulated radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison. Radiother Oncol 2007; 2 (22): 1–10.
7.Ha, P K, Hdeib, A, Goldernberg, Det al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 12–16.
8.Dietl, B, Marienhagen, J, Kuhnel, Tet al. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer—a prospective clinical analysis. Auris Nasus Larynx 2006; 33 (3): 303–309.
9.Kajitani, C, Asakawa, I, Uto, Fet al. Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer. J Radiat Res 2013; 54: 671–678.
10.Steenbakkers, R J H M, Duppen, J C, Fitton, Iet al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a ‘Big Brother’ evaluation. Radiother Oncol 2005; 77: 182–190.
11.Dos Santos, D T, Lima, E N P, Chojniak, Ret al. Topographic metabolic map of head and neck squamous cell carcinoma using 18F-FDG PET and CT image fusion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 619–625.
12.Yaremko, B, Riauka, T, Robinson, Det al. Thresholding in PET images of static and moving targets. Phys Med Biol 2005; 50: 5969–5982.
13.Hwang, A B, Bachrach, S L, Yom, S Set al. Can positron emission tomography (PET) or PET/computed tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys 2009; 73 (2): 578–584.
14.Soto, D E, Kessler, M L, Piert, Met al. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol 2008; 89 (1): 13–18.
15.Robertson, M L, Gleich, L L, Barrett, W Let al. Base-of-tongue cancer: survival, function, and quality of life after external-beam irradiation and brachytherapy. Laryngoscope 2001; 111 (8): 1362–1365.
16.Beadle, B M, Liao, K P, Elting, L Set al. Improved survival using intensity-modulated radition therapy in head and neck cancers. Cancer 2014; 120: 702–710.
17.Ang, K, Pajak, T, Wheeler, Ret al. A phase III trial to test accelerated (AFX) versus standard (SFX) fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): report of efficacy and toxicity. Int J Rad Onc Biol Phys 2010; 77 (1): 1–2.
18.Huncharek, M, Kupelnick, B.Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002; 25 (3): 219–223.
19.Wang, K, Heron, D E, Clump, D Aet al. Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation. Radiother Oncol 2013; 106: 90–95.
20.Thorwarth, D, Eschmann, S M, Scheiderbauer, Jet al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 2005; 5: 152.
21.Postema, E J, McEwan, A J, Riauka, T Aet al. Initial results of hypoxia imaging using 1-alpha-D-(5-deoxy-5-[18F]-fluoroarabinofuranyosyl)-2-nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging 2009; 36 (10): 1565–1573.
22.Troost, E G, Bussink, J, Hoffman, A Let al. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med 2010; 51 (6): 866–874.
23.Arens, A I J, Troost, E G C, Hoeben, BAWet al. Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome. Eur J Nucl Med Mol Imaging 2014; 41 (5): 915–924.
24.Hoeben, B A W, Bussink, J, Troost, E G Cet al. Molecular PET imaging for biology-guided adaptice radiotherapy of head and neck cancer. Acta Oncologica 2013; 52: 1257–1271.